GALR1 and PENK serve as potential biomarkers in invasive non-functional pituitary neuroendocrine tumours

被引:0
|
作者
Wu, Zerui [1 ,2 ]
Rao, Changjun [3 ,4 ]
Xie, Yilin [1 ,2 ]
Ye, Zhen [1 ,2 ]
Zhang, Yichao [1 ,2 ]
Ma, Zengyi [1 ,2 ]
Su, Zhipeng [4 ]
Ye, Zhao [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Cell Biol, Beijing, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Pituitary tumors; Invasion; GLAR1; PENK; GALANIN RECEPTOR-1; GENE; EXPRESSION; EPIDEMIOLOGY; ADENOMAS;
D O I
10.1016/j.gene.2025.149374
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Some nonfunctioning pituitary neuroendocrine tumor (NFPitNET) can show invasive growth, which increases the difficulty of surgery and indicates a poor prognosis. However, the molecular mechanism related to invasiveness remains to be further studied. This study is to screen and identify the characteristic biomarkers of invasive NFPitNETs. Methods: Based on the data of 73 NFPitNETs microarray chips in the GSE169498 dataset, this study used weighted gene co-expression network (WGCNA), differential expression analysis, protein-protein interaction (PPI) network analysis and various machine learning methods (XGBOOST, LASSO regression, random forest, support vector machine) to screen candidate biomarkers for invasive NFPitNET. Then, using gene set enrichment analysis (GSEA) to explore the differences in biological activities and signaling pathways between invasive NFPitNET and non-invasive NFPitNET. Single-sample GSEA (ssGSEA) was used to analyze key biomarkersrelated signaling pathways. Finally, the expression and function of the key biomarkers were verified by q-RT PCR, immunohistochemical (IHC) experiments and in vitro experiments. Results: Combined with WGCNA and differential expression analysis, 128 high-expression and 85 low-expression candidate biomarkers were preliminarily obtained. PPI analysis and four machine learning algorithms further identified GALR1, PENK and HOXD9. The receiver operating characteristic (ROC) curve results showed that the three biomarkers had good predictive ability of invasiveness. After combining the validation set data, GALR1 and PENK were the final key biomarkers. Finally, PCR and IHC results verified the decreased expression of GALR1 and PENK in invasive NFPitNET and promotes proliferation and invasive ablity of pituitary tumor cells. Conclusion: This study confirmed that the reduced expression of GALR1 and PENK is an important molecular feature of invasive NFPitNETs, which may play an important role in inhibiting the development of NFPitNET.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Non-invasive screening for neuroendocrine tumors-Biogenic amines as neoplasm biomarkers and the potential improvement of "gold standards"
    Miekus, Natalia
    Baczek, Tomasz
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 130 : 194 - 201
  • [42] Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
    Yao, James C.
    Fazio, Nicola
    Singh, Simron
    Buzzoni, Roberto
    Carnaghi, Carlo
    Wolin, Edward
    Tomasek, Jiri
    Raderer, Markus
    Lahner, Harald
    Voi, Maurizio
    Pacaud, Lida Buboteishvili
    Rouyrre, Nicolas
    Sachs, Carolin
    Valle, Juan W.
    Delle Fave, Gianfranco
    Van Cutsem, Eric
    Tesselaar, Margot
    Shimada, Yasuhiro
    Oh, Do-Youn
    Strosberg, Jonathan
    Kulke, Matthew H.
    Pavel, Marianne E.
    LANCET, 2016, 387 (10022): : 968 - 977
  • [43] Lipocalin 2, clusterin and Kim 1 as potential early, non invasive biomarkers of nephrotoxicity
    Hoffmann, D.
    Zidek, N.
    Sieber, M.
    Dekant, W.
    Mally, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 74 - 74
  • [44] A systematic review of clinical prediction models for recurrence in patients with resectable grade 1 and 2 non-functional pancreatic neuroendocrine tumors
    Chen, J. W. B.
    Heidsma, C. M.
    Kabaktepe, E.
    van Dieren, S.
    Besselink, M. G.
    van Dijkum, Nieveen E.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 103 - 103
  • [45] Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review
    Chen, Jeffrey W.
    Heidsma, Charlotte M.
    Engelsman, Anton F.
    Kabaktepe, Ertunc
    van Dieren, Susan
    Falconi, Massimo
    Besselink, Marc G.
    van Dijkum, Els J. M. Nieveen
    CANCERS, 2023, 15 (05)
  • [46] Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer
    Liu, Wenwen
    Li, Yi
    Zhang, Yan
    Shen, Xianjuan
    Su, Zhangyao
    Chen, Lin
    Cai, Weihua
    Wang, Feng
    Ju, Shaoqing
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (01)
  • [47] Is ARX/PDX1 Expression Profile Associated with Adverse Histopathologic Features Including Venous Invasion in Non-Functional Pancreatic Neuroendocrine Tumors
    Chen, Wei
    Revetta, Frank
    Shi, Chanjuan
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1819 - S1821
  • [48] Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas
    Kim, Jeong-Hwa
    Hur, Kyu-Yeon
    Hong, Sang-Duk
    Choi, Jung-Won
    Seol, Ho Jun
    Nam, Do-Hyun
    Lee, Jung-Il
    Kong, Doo-Sik
    WORLD NEUROSURGERY, 2022, 159 : E488 - E496
  • [49] 68Ga-DOTANOC uptake pattern as a prognostic factor in patients with non-functional well-differentiated G1/G2 pancreatic neuroendocrine tumours treated with 177Lu-DOTATATE
    Sampaio, I. L.
    Ferreira, G.
    Fonseca, L.
    Pedro, J.
    Gouveia, P.
    Castro, S.
    Duarte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S637 - S637
  • [50] Plasma Exosomal S1PR5 and CARNS1 as Potential Non-invasive Screening Biomarkers of Coronary Heart Disease
    Xiong, Feng
    Mao, Rui
    Zhao, Ruohan
    Zhang, Lijuan
    Tan, Kunyue
    Liu, Chunxia
    Wang, Shuzhen
    Xu, Min
    Li, Yi
    Zhang, Tongtong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9